Associations of JAK2 Mutant Allele Burden With Occurrence of CKD (Chronic Kidney Disease) and Dynamics of Kidney Function Over Time in Patients With Chronic Myeloproliferative Neoplasms

被引：0
|
作者：
Lucijanic, Marko [1 ]
Veic, Petra [2 ]
Aric, Ivona [3 ]
Tupek, Katarina Marija
Soric, Ena [1 ]
Sabljic, Anica
Glasnovic, Josipa Vlasac [1 ]
Stoos-Veic, Tajana [4 ]
Krecak, Ivan [5 ,6 ]
Kusec, Rajko [1 ,2 ]
机构：
[1] Univ Hosp Dubrava, Dept Hematol, Zagreb, Croatia
[2] Univ Zagreb, Dept Internal Med, Sch Med, Zagreb, Croatia
[3] Univ Hosp Dubrava, Clin Dept, Lab Diagnost, Zagreb, Croatia
[4] Univ Hosp Dubrava, Dept Pathol & Cytol, Zagreb, Croatia
[5] Gen Hosp Sibenik Knin Cty, Dept Internal Med, Shibenik, Croatia
[6] Univ Rijeka, Rijeka, Croatia
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷
关键词：
MPN; JAK2; chronic kidney disease;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MPN-409
引用
收藏
页码：S394 / S394
页数：1
相关论文
共 50 条
  • [1] Higher JAK2 V617F mutant allele burden in patients with chronic myeloproliferative neoplasms is associated with a higher prevalence of chronic kidney disease and unfavorable dynamics of kidney function over time
    Lucijanic, Marko
    Veic, Petra
    Aric, Ivona
    Tupek, Katarina Marija
    Soric, Ena
    Sabljic, Anica
    Vlasac Glasnovic, Josipa
    Stoos-Veic, Tajana
    Krecak, Ivan
    Kusec, Rajko
    ANNALS OF HEMATOLOGY, 2023, 102 (07) : 1955 - 1956
  • [2] Higher JAK2 V617F mutant allele burden in patients with chronic myeloproliferative neoplasms is associated with a higher prevalence of chronic kidney disease and unfavorable dynamics of kidney function over time
    Marko Lucijanic
    Petra Veic
    Ivona Aric
    Katarina Marija Tupek
    Ena Soric
    Anica Sabljic
    Josipa Vlasac Glasnovic
    Tajana Stoos-Veic
    Ivan Krecak
    Rajko Kusec
    Annals of Hematology, 2023, 102 : 1955 - 1956
  • [3] Specific symptom burden in patients with chronic myeloproliferative neoplasms and chronic kidney disease
    Holik, Hrvoje
    Lucijanic, Marko
    Krecak, Ivan
    ANNALS OF HEMATOLOGY, 2023, 102 (07) : 1963 - 1965
  • [4] Specific symptom burden in patients with chronic myeloproliferative neoplasms and chronic kidney disease
    Hrvoje Holik
    Marko Lucijanic
    Ivan Krecak
    Annals of Hematology, 2023, 102 : 1963 - 1965
  • [5] JAK2 ALLELE BURDEN IN PATIENTS WITH PHILADELPHIA NEGATIVE MYELOPROLIFERATIVE NEOPLASMS
    Napolitano, M.
    Siragusa, S.
    Mancuso, S.
    Santoro, M.
    Cariccio, M. R. Lanza
    Bono, M.
    Di Piazza, F.
    Russo, A.
    Accurso, V.
    HAEMATOLOGICA, 2017, 102 : 811 - 811
  • [6] Chronic kidney disease and thrombotic risk in patients with chronic myeloproliferative neoplasms
    Marko Lucijanic
    Ivan Krecak
    Journal of Thrombosis and Thrombolysis, 2023, 55 : 760 - 761
  • [7] Chronic kidney disease and thrombotic risk in patients with chronic myeloproliferative neoplasms
    Lucijanic, Marko
    Krecak, Ivan
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2023, 55 (04) : 760 - 761
  • [8] IMPACT OF THE JAK2 (V617F) MUTATION AND THE MUTANT ALLELE BURDEN ON DISEASE PROGRESSION IN CHRONIC MYELOPROLIFERATIVE DISORDERS
    Passamonti, F.
    Rumi, E.
    Pietra, D.
    Boveri, E.
    Pascutto, C.
    Lazzarino, M.
    Cazzola, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 298 - 299
  • [9] JAK2 Exon 14 Deletion in Patients with Chronic Myeloproliferative Neoplasms
    Ma, Wanlong
    Kantarjian, Hagop
    Zhang, Xi
    Wang, Xiuqiang
    Zhang, Zhong
    Yeh, Chen-Hsiung
    O'Brien, Susan
    Giles, Francis
    Bruey, Jean Marie
    Albitar, Maher
    PLOS ONE, 2010, 5 (08):
  • [10] JAK2 V617F ALLELE BURDEN IN CHRONIC MYELOPROLIFERATIVE DISEASES
    Skerget, Matevz
    Pajic, Tadej
    Kralj, Eva
    Vuckovic, Josko
    ZDRAVNISKI VESTNIK-SLOVENIAN MEDICAL JOURNAL, 2008, 77 : I57 - I61
12345